1. Lehrer S, Rheinstein PH. Nasal steroids as a possible treatment for Alzheimer's disease. Discov Med. 2017 Oct;24(132):147-152. PubMed PMID: 29272691. HTML

  2. Lehrer S, Rheinstein PH, Rosenzweig KE. Association of Radon Background and Total Background Ionizing Radiation with Alzheimer's Disease Deaths in U.S.
    States. J Alzheimers Dis. 2017;59(2):737-741. doi: 10.3233/JAD-170308. PubMed PMID: 28671130. pdf

  3. Lehrer S. and Rheinstein P. A derangement of the brain wound healing process may cause some cases of Alzheimer's disease. Discov Med. 2016 Aug;22(119):43-6. HTML pdf

  4. Lehrer S. and Rheinstein P. Relation of Poor Memory to Soluble Tumor Necrosis Factor Receptor Type Two (sTNF-RII). Am J Alzheimers Dis Other Demen. 2015 December pdf

  5. Lehrer S. and Rheinstein P. Two compartment model of MSH/ACTH may be a surrogate for intranasal insulin central nervous system kinetics. Journal of Alzheimer's Disease 31 July 2015. pdf  HTML

  6. Lehrer S. Adverse Side Effects of Intranasal Detemir Insulin in the SNIFF Trial. Journal of Alzheimer's Disease 4 June 2015. pdf  HTML

  7. Lehrer S. and Rheinstein P. Is Alzheimer’s Disease Autoimmune Inflammation of the Brain That Can be Treated With Nasal Nonsteroidal Anti-Inflammatory Drugs? Am J Alzheimers Dis Other Demen.  2015 May;30(3):225-7. pdf

  8. Lehrer S. Nasal NSAIDs for Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2014 Jan 9;29(5):401-403. pdf

  9. Lehrer S. Inhaled Thyrotropin-Releasing Hormone for Treatment of Neuropsychiatric Disorders. J Clin Psychopharmacol. 2014 Apr;34(2):288-90 pdf

  10. Lehrer S, Rheinstein P, Mulshine J. Inhaled buformin for lymphangioleiomyomatosis and early (airway confined) lung cancer. American Association for Cancer Research Annual Meeting Abstracts 2014;14-A-638-AACR. pdf

  11. Lehrer S, Rheinstein P. Increased maternal compared to paternal transmission of Alzheimer’s Disease may be due to increased incidence of depression in women. 2023 Jun pdf